| G3BP1 controls the senescence-associated secretome and its impact on cancer progression A Omer, MC Barrera, JL Moran, XJ Lian, S Di Marco, C Beausejour, ... Nature communications 11 (1), 4979, 2020 | 65 | 2020 |
| Clinical and parasitological features of patients with American cutaneous leishmaniasis that did not respond to treatment with meglumine antimoniate JE Perez-Franco, ML Cruz-Barrera, ML Robayo, MC Lopez, CD Daza, ... PLoS neglected tropical diseases 10 (5), e0004739, 2016 | 47 | 2016 |
| Integrated analysis of transcriptome and secretome from umbilical cord mesenchymal stromal cells reveal new mechanisms for the modulation of inflammation and immune activation M Cruz-Barrera, N Flórez-Zapata, N Lemus-Diaz, C Medina, CC Galindo, ... Frontiers in Immunology 11, 575488, 2020 | 29 | 2020 |
| The effect of Lucilia sericata-and Sarconesiopsis magellanica-derived larval therapy on Leishmania panamensis L Cruz-Saavedra, A Díaz-Roa, MA Gaona, ML Cruz, M Ayala, ... Acta tropica 164, 280-289, 2016 | 28 | 2016 |
| Strategy for the generation of engineered bone constructs based on umbilical cord mesenchymal stromal cells expanded with human platelet lysate I Silva-Cote, M Cruz-Barrera, M Cañas-Arboleda, L Correa-Araujo, ... Stem cells international 2019 (1), 7198215, 2019 | 24 | 2019 |
| Improving leishmania species identification in different types of samples from cutaneous lesions EMC Cruz-Barrera ML, Ovalle-Bracho C, Ortegon-Vergara V, Pérez-Franco JE J Clin Microbiol. 53 (4), 2015 | 21 | 2015 |
| Características de cultivos celulares primarios derivados de Sarconesiopsis magellanica (Le Guillou, 1842)(Diptera: Calliphoridae) M Cruz, FJ Bello Revista UDCA Actualidad & Divulgación Científica 15 (2), 313-321, 2012 | 4 | 2012 |
| Establishment and Characterization of an Embryonic Cell Line from Sarconesiopsis magellanica M Cruz, FJ Bello J Insect Sci. 13, 15, 2013 | 1 | 2013 |
| Large and small extracellular vesicles derived from Wharton’s Jelly mesenchymal stromal cells: biophysics, function and molecular strategies to improve immune modulation JC Buitrago, M Cruz-Barrera, V Dorsant-Ardón, C Medina, ... Molecular Therapy Methods & Clinical Development, 2024 | | 2024 |
| Comprehensive analysis of secretome and transcriptome stability of Wharton jelly mesenchymal stromal cells during good manufacturing practice-compliant production M Cañas-Arboleda, CC Galindo, M Cruz-Barrera, K Herrera, K Beltrán, ... Cytotherapy, 2024 | | 2024 |
| METHOD FOR STIMULATION OF MESENCHYMAL CELLS TO INDUCE IMMUNOMODULATORY FACTOR EXPRESSION GASL Mariana CAÑAS ARBOLEDA, Monica Liliana CRUZ BARRERA WO Patent WO2022074624A1, 2023 | | 2023 |
| Differentially expressed miRNAs in human Wharton's Jelly mesenchymal stromal cells-derived extracellular vesicles: revealing potential mechanisms of action in immune modulation JC Buitrago, V Dorsant, M Cruz-Barrera, N Florez, B Camacho, J Gruber, ... HUMAN GENE THERAPY 32 (19-20), A151-A152, 2021 | | 2021 |
| Células estromales mesenquimales de gelatina de wharton inducen re-programación de macrófagos inflamatorios hacia un fenotipo inmunomodulador ML Cruz-Barrera, B Camacho, GA Salguero Medicina (Bogotá), 161-161, 2018 | | 2018 |
| Engineered extracellular vesicles derived from human mesenchymal stromal cells expressing CD9, show enhanced immune supresion effects on inflammatory T cells M Cruz-Barrera, KO Boeker, N Lemus-Diaz, J Gruber, B Camacho, ... HUMAN GENE THERAPY 28 (12), A86-A86, 2017 | | 2017 |
| Primary cell cultures derived from Sarconesiopsis magellanica (Le Guillou, 1842)(Diptera: Calliphoridae) M Cruz B, FJ Bello Revista UDCA Actualidad & Divulgación Científica 15 (2), 313-321, 2012 | | 2012 |
| CARACTERÍSTICAS DE CULTIVOS CELULARES PRIMARIOS DERIVADOS DE M Cruz, FJ Bello Sarconesiopsis magellanica, 313-321, 1842 | | 1842 |
| MANIKANDAN VELSITHARTH, HOFMANN BRIDGER, NAVUKKARASU RAJENDRAN AATTRALARASU L Bagno, KE Hatzistergos, W Balkan, JM Hare, A Omer, MC Barrera, ... DISCOVERY PHASE OF MEDICAL RESEARCH, 111, 0 | | |
Felio BelloProfesor. Universidad de La Salle在 unisalle.edu.co 的电子邮件经过验证
